Position in MRK
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,343,724
+$37,736 QoQ
Shares Held
10,457
-3.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,875
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Gilman Hill Asset Management, LLC holds $40,633,070 across 8 Drug Manufacturers - General names. MRK ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
231,255 | $13,324,913 | |
| 2 | PFE |
Pfizer Inc
|
428,237 | $10,311,946 | |
| 3 | GSK |
GSK plc
|
128,768 | $6,750,018 | |
| 4 | ABBV |
AbbVie Inc.
|
13,594 | $3,420,794 | |
| 5 | JNJ |
Johnson & Johnson
|
12,793 | $3,249,038 | |
| 6 | LLY |
ELI LILLY & Co
|
1,606 | $1,926,284 | |
| 7 | MRK |
Merck & Co., Inc.
This page
|
10,457 | $1,343,724 | |
| 8 | AMGN |
Amgen Inc
|
846 | $306,353 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,343,724 | 10,457 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,305,988 | 10,857 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $1,181,754 | 11,227 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $868,843 | 10,352 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $818,356 | 10,338 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,037,894 | 11,563 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $1,181,026 | 11,872 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,458,905 | 12,847 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,639,483 | 13,243 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,592,372 | 12,068 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,325,029 | 12,154 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,262,064 | 12,259 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $1,415,142 | 12,264 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,292,000 | 12,144 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,434,916 | 12,933 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,210,502 | 14,056 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $1,217,301 | 13,352 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,154,525 | 14,071 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $999,002 | 13,035 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $987,996 | 13,154 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $979,357 | 12,593 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $871,194 | 11,301 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $918,040 | 11,223 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $817,721 | 9,858 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $774,692 | 10,018 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $746,009 | 9,696 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||